CVAC Competitors & Alternatives
Compare CureVac NV with similar stocks in the same industry
Biotechnology
CVAC
Main Stock$4.66
Tradestie Score
54
Market Cap
$1.22B
P/E Ratio
7.0
Revenue Growth
-0.9%
Analyst Upside
+15.6%
Top Competitors
236 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NKTR
Nektar Therapeutics
|
$69.76
|
$1.12B | - | 56 | Compare |
|
PRAX
Praxis Precision Medicines, Inc. Common Stock
|
$334.58
|
$1.12B | - | 51 | Compare |
|
IMTX
Immatics N.V. Ordinary Shares
|
$8.79
|
$1.09B | - | 43 | Compare |
|
PHAR
Pharming Group N.V. ADS, each representing 10 ordinary shares
|
$11.21
|
$1.05B | 77.2 | 42 | Compare |
|
MDXG
MiMedx Group, Inc
|
$4.57
|
$1.01B | 115.0 | 47 | Compare |
|
SPRY
ARS Pharmaceuticals, Inc. Common Stock
|
$4.76
|
$997.16M | - | 45 | Compare |
|
PRME
Prime Medicine, Inc. Common Stock
|
$3.13
|
$996.55M | - | 41 | Compare |
|
SYRE
Spyre Therapeutics, Inc. Common Stock
|
$90.60
|
$994.20M | - | 66 | Compare |
|
VALN
Valneva SE American Depositary Shares
|
$6.66
|
$993.46M | - | 45 | Compare |
|
IMNM
Immunome, Inc.
|
$24.67
|
$987.09M | - | 44 | Compare |
More CVAC Analysis
Data updated: Sep 13, 2026 | Industry: Biotechnology (SIC 2834)
236 stocks in this industry